Pharmaceutical and Medical Device Manufacturing

01Purpose and scope

• This manual supports the course Pharmaceutical and Medical Device Manufacturing. It is written as a working reference for people who make, release, test, or support products that are regulated as drugs, biologics, or medical devices, including operators, supervisors, quality staff, validation engineers, and production planners.
• The scope covers the day-to-day discipline of making product under a documented quality system: preparing equipment and facilities, executing batch or lot instructions, controlling materials and components, documenting what happened, investigating deviations, and keeping the operation ready for inspection. It does not teach product design, clinical evaluation, or the chemistry of drug synthesis in depth, although those topics shape what the plant must control.
• Pharmaceutical and device work share a common logic but differ in detail. Drug manufacturing is usually organized around batches of a formulated product with defined process steps, sterility or purity requirements, and release testing. Device manufacturing is often organized around lots or serialized units, with design controls upstream, assembly and sterilization steps, and traceability to components and suppliers. A plant that makes both needs clear boundaries between the two rulebooks.
• This guidance does not replace qualified professional judgment, approved site procedures, or required authorization from the responsible quality unit. Requirements vary by jurisdiction and by product type, so confirm current obligations with the authoritative regulator for your market and with your own quality agreement.

02Core principles

• The central idea is that quality is built into the process and proven by records, not inspected in at the end. A tablet that passes assay testing still fails if the blend was not homogeneous or if the operator skipped a required in-process check. Every step should therefore have a defined method, a defined acceptance range, and a record that shows the step was done by a qualified person.
• Control of the environment and of materials is the second principle. Particulate and microbial contamination, cross contamination between products, mix-ups between components, and mislabeling are the failures that most often lead to recalls. Facility zoning, gowning rules, cleaning verification, material status labels, and segregated quarantine areas exist to make these failures harder to produce.
• Third, changes are controlled. Any change to a validated process, equipment, material supplier, software, or procedure needs a documented assessment of its effect on product quality before it is implemented. Small changes made quietly on a production floor are a common source of later problems.
• Finally, the quality unit has independent authority to hold, reject, or release product. Production supervisors have pressure to meet schedules, and the system works only when the quality unit can stop a batch without having to win an argument with the plant manager.

03Planning and preparation

• Good execution starts before the batch. Confirm that the product specification, master production record or device master record, and approved procedures are the current revisions. Check that the equipment is qualified for the intended use, that calibration is current, that preventive maintenance is complete, and that the area has been cleaned and released with a documented clearance. Many late-stage batch failures trace back to a missed item on this list.
• Materials are the next focus. Verify that each component has passed incoming inspection or is covered by an approved supplier certificate, that its status is recorded as released, and that the lot number matches the batch instruction. Check expiry or retest dates against the planned run. For devices, confirm that sterilization packaging, labeling stock, and any purchased subassemblies carry the correct revision.
• Staffing and training need the same care. Each person in the run should be trained on the specific procedure they will perform, and that training should be documented before they work unsupervised. Where a role requires a qualification, such as a validated sterilization operator or a person authorized to sign a release step, confirm it is on file.
• Plan for the trade-offs. A tight schedule pushes teams to shorten cleaning or combine steps, while a conservative approach adds hold points and sampling that lengthen the run. The right balance depends on product risk, the maturity of the process, and the results of recent runs. For a new product or a newly transferred process, expect more sampling and slower release decisions than for a mature product with a long, stable history.

04Recommended workflow

1. 1
   : Review the batch or lot package before the first operation. Confirm the order, the approved revision of each instruction, the material list, the label set, and the required equipment. Resolve any discrepancy with the quality unit before work begins, not during the run.
2. 2
   : Set up and verify the line. Install the correct tooling, filters, or fixtures, record equipment identification numbers, and perform the required line clearance. Have a second person verify critical setup items when the procedure requires it, and record that verification.
3. 3
   : Dispense and process materials under controlled conditions. Weigh or count components against the batch instruction, record actual quantities and balance identifiers, and keep components in labeled containers. For sterile operations, follow the approved gowning, entry, and intervention rules without exception.
4. 4
   : Perform in-process checks at the defined points. Typical checks include weight variation, fill volume, seal integrity, dimensional measurements on device components, or bioburden sampling where it applies. Record the actual result, not a pass mark, and act immediately on any result outside the limit by following the stop and escalate procedure.
5. 5
   : Handle deviations as they occur. A deviation is any departure from an approved instruction or expected condition. Record it at the time it happens, describe what occurred, notify the supervisor and quality, and do not continue the affected step until a disposition is documented. Attempting to fix a problem quietly is one of the most serious practice failures in this field.
6. 6
   : Complete the batch record and reconcile materials. Compare issued, used, returned, and rejected quantities. Reconcile labels and packaging components. Check that every entry is complete, legible, dated and signed according to the site procedure, and that corrections follow good documentation practice with the original entry still visible.
7. 7
   : Submit for review and disposition. The quality unit reviews the complete record, including deviations, test results, and any environmental or equipment data. Product is released, held for further testing, or rejected based on that review. Only after disposition should the product move to finished goods storage and distribution.

05Quality checks, risk controls and compliance

• Risk management shapes where controls are placed. Many sites use the principles in ICH Q9 for pharmaceutical quality risk management and ISO 14971 for medical device risk management. Both ask the same question: what could go wrong, how serious would it be for the patient, how likely is it, and how well can we detect it? The answer determines how much sampling, verification, or procedural redundancy a step needs.
• Quality checks fall into three groups. Process checks confirm the operation is running within its validated parameters. Product checks test the output against specification, such as assay, dissolution, sterility, dimensions, or functional testing. Environmental and utility checks cover air quality, water quality, pressure differentials, and sterilizer cycle records. Trends across these groups often reveal problems earlier than any single failed result.
• Compliance frameworks differ by product and market. In the United States, drug manufacturing is governed by the current good manufacturing practice regulations in 21 CFR Parts 210 and 211, and device manufacturing by the quality system requirements in 21 CFR Part 820, which is being updated to align with ISO 13485. In the European Union, sterile product manufacturing is addressed in the EU GMP guidance including Annex 1. ISO 13485 is widely used as a device quality management system standard. Check the current text of each rule that applies to your product, because these documents change.
• Data integrity is a compliance focus in its own right. Electronic records must be attributable, legible, contemporaneous, original, and accurate, with audit trails that cannot be turned off by operators. Shared logins, back-dated entries, and undocumented data deletion are treated as serious findings, and they often lead to regulatory action regardless of the product quality results.

06Collaboration and documentation

• Manufacturing sits between engineering, quality, supply chain, regulatory affairs, and sometimes the contract partner or the sterilizer. Each group needs a defined interface. Engineering owns equipment change assessments with manufacturing input, quality approves changes and deviation dispositions, and supply chain manages supplier qualification and receiving. Writing these responsibilities into the quality agreement or site procedures prevents disputes during a deviation.
• Documentation is the working memory of the operation. Standard operating procedures, batch records, equipment logs, training records, and change records should be controlled documents with version numbers, approval signatures, and a clear method for retrieval. A procedure that is printed and taped to a wall but not under document control is a finding waiting to happen.
• Handover between shifts needs its own discipline. A short, structured handover that lists open deviations, equipment status, materials on hold, and in-process results prevents the next shift from restarting a step or repeating a sample. Keep handover notes as formal records when the site procedure requires them.
• Expect friction between speed and documentation. Operators may see paperwork as delay, and engineers may see procedures as bureaucracy. The practical answer is to make the record easy to complete at the point of work, with clear fields, and to explain why each entry matters in terms of patient safety and product release.

07Measures and continuous improvement

• Plants track a set of indicators to see whether the system is working. Common measures include first-pass yield, right-first-time batch release rate, number and type of deviations per batch, percentage of deviations closed within the procedure timeline, environmental monitoring trends, equipment downtime, complaint rate for devices, and results of internal audits. A single number rarely tells the story, so review these together and look for patterns.
• Set targets with care. A target that is too aggressive encourages teams to under-report deviations, which hides problems. A useful practice is to measure how many deviations are raised and how quickly they are investigated, and to treat a rising count after a training push as a sign the reporting culture is improving rather than failing.
• Continuous improvement works through structured investigation. Root cause analysis methods such as five whys or fishbone diagrams help, but the quality of the conclusion depends on the evidence gathered. Corrective and preventive actions should be specific, assigned, time-bound, and checked for effectiveness after a defined period.
• Process changes that come out of improvement work still follow change control. A proposed improvement that reduces a hold time or changes a set point needs validation or justification before use. Improvement is valuable only when it is made safely and recorded.

08Common mistakes and how to prevent them

• Recording results after the fact is one of the most common failures. Operators write values at the end of a shift from memory or from a scrap sheet. Prevent it by placing the record at the point of work, requiring entries before the next step can proceed, and auditing a sample of entries against raw data.
• Skipping line clearance after a changeover causes mix-ups and cross contamination. The fix is a visible clearance checklist that the quality unit or a trained second person signs, with the clearance status shown on the equipment itself.
• Treating a minor deviation as closed without investigation hides trends. Every deviation should be classified, and the classification should be reviewed by quality, not just by the person who raised it. Repeated small deviations on the same step deserve a formal look.
• Relying on end-product testing to catch process problems is risky. Testing samples a small fraction of output and cannot prove every unit is good. Strengthen in-process controls and trend data instead of adding more final tests.
• Allowing unqualified people to perform critical steps happens when staffing is short. The safeguard is a training matrix linked to access control, so that a person cannot log into a critical station without current qualification.

09Practical checklist

• Confirm current approved revisions of the batch record, procedures, and specifications before starting.
• Verify equipment calibration, maintenance status, and line clearance with a signed record.
• Check that all materials are labeled with the correct lot number and released status.
• Record each in-process result at the point of work, with actual values and the balance or instrument used.
• Stop and escalate immediately on any out-of-limit result or unexpected condition, and document a deviation.
• Reconcile material quantities and label usage before submitting the batch for review.
• Confirm that audit trails are active and that no shared logins are in use on electronic systems.
• Complete a structured handover that lists open items, holds, and pending test results.

★Learning sources

• Micro Degree: Pharmaceutical and Medical Device Manufacturing
• Micro Degree: Solar Power Systems
• Micro Degree: Energy Management and Audit
• Micro Degree: Industry 4.0 Technologies